Anavex Life Sciences Corp (AVXL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $75.79M
Last updated: Nov 17, 2026 at 4:40 PM ET
Anavex Life Sciences Corp (AVXL) Stock Chart
Anavex Life Sciences (AVXL) has a latest price of $0.74 on Nov 17, 2026. Its price fell 79.7% over the past 12 months. The month-end price fell 57.3% over the 10 years through Oct 2026, a compound annual decline of 8.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $22.86 in Jun 2021 and its lowest $1.19 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart AVXL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AVXL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 78.2%, and over 6 months it fell 72.3%. The month-end price fell 78.7% over the 3 years through Oct 2026, a compound annual decline of 40.3%.
| Period | Change |
|---|---|
| 1 month | -40.8% |
| 3 months | -78.2% |
| 6 months | -72.3% |
| 12 months | -79.7% |
| 12 months, with dividends | -79.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -78.7% | -40.3% |
| 5 years | -93.6% | -42.4% |
| 10 years | -57.3% | -8.2% |
Price by Year
Its best calendar year was 2021, when the price rose 221.1%, and its weakest was 2025, when it fell 66.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.19 | -66.6% |
| 2025 | $3.56 | -66.9% |
| 2024 | $10.74 | +15.4% |
| 2023 | $9.31 | +0.5% |
| 2022 | $9.26 | -46.6% |
| 2021 | $17.34 | +221.1% |
| 2020 | $5.40 | +108.5% |
| 2019 | $2.59 | +66.0% |
| 2018 | $1.56 | -51.6% |
| 2017 | $3.22 | -18.7% |
Trading Range
The price is 55.7% below its 50-day average of $1.67 and 74.1% below its 200-day average of $2.86.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.74 | |
| 50-day average | $1.67 | -55.7% |
| 200-day average | $2.86 | -74.1% |
Price Risk
Over 3 years, its largest fall from a peak was 94.5%.
| Measure | Value |
|---|---|
| 1-year beta | 2.13 |
| Largest fall, 1 year | -86.0% |
| Largest fall, 3 years | -94.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About AVXL
What is AVXL's 1-year price change?
Anavex Life Sciences's price fell 79.7% over the past 12 months. With dividends included, the 12-month total return was -79.7%.
What is AVXL's 5-year price change?
Anavex Life Sciences's month-end price fell 93.6% over the 5 years through Oct 2026, a compound annual decline of 42.4%. These figures leave out dividends.
What is AVXL's beta?
Anavex Life Sciences's 1-year beta against the S&P 500 is 2.13, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 86.0%.
Is the AVXL chart free?
Yes. Advanced Charting for AVXL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
AVXL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics